Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fischer Pharmaceuticals, widely recognized by its Dr. Fischer brand, is a prominent international pharmaceutical and dermo-cosmetic company headquartered in Israel. Established in 1965 by Dr. Eli Fischer, the company specializes in the research, development, and manufacture of advanced healthcare products with a focus on ophthalmology, dermatology, and hygiene. Their extensive portfolio includes sterile ophthalmic drops, therapeutic skin care, sun protection, and pediatric health products. Fischer Pharmaceuticals operates large-scale, GMP-certified manufacturing facilities and exports its diverse range of over-the-counter and prescription treatments to over 30 countries. The company is a leader in the Israeli healthcare market and maintains a strong global presence through strategic distribution and private label partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fischer Pharmaceuticals.